CVS Health (CVS) Financials: History & Chart

CVS Health Corp. (CVS)CVSCVS Health Corp.

About CVS Health Corp.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Woonsocket, RI

300,000 employees

www.cvshealth.com

Healthcare / Medical - Healthcare Plans

Sector: Healthcare
Industry: Medical - Healthcare Plans
CEO: J. David Joyner

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Revenue	407.90B	100.43B	105.69B	102.87B	98.92B	94.59B	97.71B	95.43B	91.23B
Cost of Goods Sold	351.31B	84.80B	92.13B	89.06B	85.32B	80.19B	84.81B	82.87B	77.85B
Gross Profit	56.59B	15.62B	13.57B	13.81B	13.59B	14.40B	12.90B	12.56B	13.38B
Gross Profit Margin	13.9%	15.6%	12.8%	13.4%	13.7%	15.2%	13.2%	13.2%	14.7%
Total Operating Expenses	50.62B	10.94B	11.46B	17.01B	11.21B	11.02B	10.53B	11.73B	10.34B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Income (EBIT)	5.97B	4.68B	2.11B	-3.21B	2.38B	3.37B	2.37B	832.00M	3.04B
Operating Margin	1.5%	4.7%	2.0%	-3.1%	2.4%	3.6%	2.4%	0.9%	3.3%
Income Before Tax (EBT)	3.46B	3.94B	1.35B	-3.48B	1.65B	2.62B	2.13B	105.00M	2.34B
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	3.11B	774.00M	787.00M	784.00M	763.00M	785.00M	758.00M	752.00M	732.00M
Other Income/Expense	-2.51B	-742.00M	-758.00M	-275.00M	-734.00M	-757.00M	-242.00M	-727.00M	-708.00M
Net Income	2.93B	2.94B	2.94B	-3.98B	1.02B	1.78B	1.64B	87.00M	1.77B
Income Tax Expense	568.00M	995.00M	-1.57B	508.00M	634.00M	835.00M	503.00M	34.00M	569.00M
Net Profit Margin	0.7%	2.9%	2.8%	-3.9%	1.0%	1.9%	1.7%	0.1%	1.9%
EBITDA	10.53B	5.79B	3.26B	-2.07B	3.55B	4.53B	3.52B	1.99B	4.20B
EBITDA Margin	2.6%	5.8%	3.1%	-2.0%	3.6%	4.8%	3.6%	2.1%	4.6%
Depreciation & Amortization	4.57B	1.11B	1.15B	1.13B	1.17B	1.15B	1.15B	1.16B	1.15B
EPS Basic	2.31	2.31	2.32	-3.13	0.81	1.41	1.31	0.07	1.41
EPS Diluted	2.27	2.30	2.30	-3.13	0.80	1.41	1.30	0.07	1.41
Shares Outstanding	1.27B	1.27B	1.27B	1.27B	1.27B	1.26B	1.26B	1.26B	1.26B
Diluted Shares Outstanding	1.28B	1.28B	1.28B	1.27B	1.27B	1.26B	1.26B	1.26B	1.26B

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	402.07B	372.81B	357.78B	322.47B	292.11B	268.71B	256.78B	194.58B
Cost of Goods Sold	346.70B	321.41B	303.35B	267.96B	239.99B	219.66B	211.25B	163.04B
Gross Profit	55.36B	51.40B	54.43B	54.50B	52.12B	49.05B	45.53B	31.54B
Gross Profit Margin	13.8%	13.8%	15.2%	16.9%	17.8%	18.3%	17.7%	16.2%
Total Operating Expenses	44.98B	42.88B	40.69B	46.55B	38.81B	35.13B	33.54B	27.52B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	0.00	41.23B	0.00	0.00	0.00	0.00	0.00	0.00
Operating Income (EBIT)	10.38B	8.52B	13.74B	7.95B	13.31B	13.91B	11.99B	4.02B
Operating Margin	2.6%	2.3%	3.8%	2.5%	4.6%	5.2%	4.7%	2.1%
Income Before Tax (EBT)	2.14B	6.15B	11.17B	5.84B	10.54B	9.77B	9.00B	1.41B
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	3.12B	2.96B	2.66B	2.29B	2.50B	2.91B	3.04B	2.62B
Other Income/Expense	-8.25B	-2.37B	-2.57B	-2.12B	-2.77B	-4.14B	-2.99B	-2.62B
Net Income	1.77B	4.61B	8.34B	4.31B	8.00B	7.18B	6.63B	-594.00M
Income Tax Expense	408.00M	1.56B	2.81B	1.51B	2.55B	2.57B	2.37B	2.00B
Net Profit Margin	0.4%	1.2%	2.3%	1.3%	2.7%	2.7%	2.6%	-0.3%
EBITDA	14.99B	13.11B	18.11B	12.18B	17.80B	18.35B	16.36B	6.74B
EBITDA Margin	3.7%	3.5%	5.1%	3.8%	6.1%	6.8%	6.4%	3.5%
Depreciation & Amortization	4.61B	4.60B	4.37B	4.22B	4.49B	4.44B	4.37B	2.72B
EPS Basic	1.40	3.66	6.49	3.29	6.00	5.48	5.10	-0.57
EPS Diluted	1.39	3.66	6.47	3.26	5.95	5.46	5.08	-0.57
Shares Outstanding	1.27B	1.26B	1.28B	1.31B	1.32B	1.31B	1.30B	1.04B
Diluted Shares Outstanding	1.27B	1.26B	1.29B	1.32B	1.33B	1.31B	1.30B	1.04B

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.